Expression of metabotropic glutamate 5 receptors in the striatum and cortex and effects of modulators on the severity of dystonia in the phenotypic dtsz model.

Abstract

The metabotropic glutamate 5 (mGlu5) receptor has been suggested as therapeutic target for L-Dopa-induced dyskinesia which is often associated with dystonic symptoms. Therefore, we investigated the acute effects of the non-competitive mGlu5 receptor antagonist fenobam as well as the positive modulator 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB) on the severity of inherited dystonia in the mutant dtsz hamster, a phenotypic model with age-dependent episodes of dystonia. Fenobam did not exert significant antidystonic effects (20-50 mg/kg intraperinoneal, i.p.). CDPPB (10, 20 mg/kg i.p.) which was expected to worsen dystonia also failed to show any effects on the severity of dystonia. Interestingly, CDPPB caused axial dyskinesia in addition to the dystonic symptoms in mutant hamsters. This adverse effect could not be observed in non-dystonic control hamsters, indicating possible changes in the expression of mGlu5 receptors in dystonic hamsters. The mGlu5 receptor mRNA did not differ between the dtsz mutant and control hamsters, while immunohistochemical studies indicated that the mGlu5 receptor expression was about 35% higher in striatum and cortex of mutant hamsters at the age of high dystonia severity scores, notably not after spontaneous remission of dystonia, compared to age-matched controls. This difference in mGlu5 receptor protein may be due to altered protein conformation instead of protein level, as western blots revealed similar amounts of monomeric and dimeric protein in mutant hamsters versus control. Thus, the present data do not provide clear evidence for an important role of the mGlu5 receptor in the pathophysiology and as a therapeutic target for types of inherited dystonia.

• Authors: Stefanie Perl, Franziska Richter, Birthe Gericke, Angelika Richter
• Journal: European journal of pharmacology (Eur J Pharmacol) Vol. 859 Pg. 172527 (Sep 15 2019) ISSN: 1879-0712 [Electronic] Netherlands
• PMID: 31283933 (Publication Type: Journal Article)
• Copyright: Copyright © 2019 Elsevier B.V. All rights reserved.

Chemical References

• 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide
• Benzamides
• Pyrazoles
• Receptor, Metabotropic Glutamate 5

Topics

• Allosteric Regulation (drug effects)
• Animals
• Benzamides (pharmacology)
• Cerebral Cortex (drug effects, metabolism)
• Cricetinae
• Dystonia (genetics, metabolism)
• Female
• Gene Expression Regulation (drug effects)
• Male
• Neostriatum (drug effects, metabolism)
• Phenotype
• Pyrazoles (pharmacology)
• Receptor, Metabotropic Glutamate 5 (genetics, metabolism)